Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine Pump in Early Stage of Parkinson's Disease
NCT02864004Phase 3Completed
- Sponsor
- CHU Rennes
- Start
- Mar 2017
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apomorphine in Parkinson's disease (PD), sponsored by CHU Rennes. Started Mar 2017; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02864004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02864004.